Pendley, Baudin & Coffin is proud to announce that Evan Fontenot has joined the firm as an Associate Attorney. Mr. Fontenot received his law degree from Louisiana State University's Paul M. Hebert Law Center, where he practiced as a student clinician in the Immigration Law Clinic and participated in the Trial Advocacy Program. In 2017 he was awarded the Dean's scholar Award. Mr. Fontenot received his Juris Doctor and Graduate Diploma in comparative Law and was admitted to the State Bar of Louisiana in October of this year.
On September 26, 2017, Pendley, Baudin & Coffin, L.L.P. filed the first pending federal lawsuit in Baton Rouge, Louisiana concerning a failure of a DePuy Attune knee implant. The plaintiff underwent a subsequent surgery to remove and replace the defective Attune device.
Click here for more information.
More information can be found on the settlement here.
CAMDEN, NJ, Aug. 1, 2017 – A Japanese pharmaceutical company, Daiichi Sankyo, will pay $300 million to settle thousands of federal and state court lawsuits over its top-selling blood pressure drugs, Benicar, Benicar HCT, Azor and Tribenzor, according to an announcement made today by the lead Plaintiffs’ lawyers in U.S. federal district court.
PBC is pursuing litigation against Atlas Roofing Corporation on behalf of people who purchased the company’s defective Chalet roofing shingles.
In a new safety alert, the FDA is warning of a dangerous risk of leg and foot amputations stemming from canagliflozin, the active ingredient in both Invokamet and Invokana, two widely used diabetes drugs. The FDA released the safety alert after reviewing the final results from two different clinical trials that looked at the drugs and their long-lasting effects over a large sample of patients suffering from type 2 diabetes.
If you have breast implants and were subsequently diagnosed with blood cancer, we are currently evaluating cases and would like to hear from you.
The FDA has recalled all Zimmer Biomet Comprehensive Reverse Shoulder replacement devices because of increasingly dangerous fracture rates. The FDA issued a Class I recall, saying that the Zimmer Biomet shoulder devices are fracturing at a higher rate than claimed by the manufacturer. The fracture rate raises the risk of serious injuries for patients who were implanted with the shoulder replacement device.
The team at Pendley, Baudin & Coffin is currently investigating cases involving injury to infants and children from Hyland’s homeopathic teething tablets and gels.